Clene Inc.

11.36+0.2200+1.97%Vol 159.40K1Y Perf 25.42%
Jun 14th, 2021 16:00 DELAYED
BID11.30 ASK11.44
Open11.14 Previous Close11.14
Pre-Market- After-Market-
 - -  - -%
Target Price
22.25 
Analyst Rating
— — 0.00
Potential %
95.86 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap676.76M 
Earnings Rating
Price Range Ratio 52W %
49.95 
Earnings Date
2nd Aug 2021

Today's Price Range

11.0711.84

52W Range

6.2316.50

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
-2.07%
1 Month
55.62%
3 Months
-21.11%
6 Months
-
1 Year
25.42%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
CLNN11.360.22001.97
AAPL130.483.13002.46
GOOG2 527.0413.11000.52
MSFT259.892.00000.78
XOM62.07-0.1000-0.16
WFC45.15-0.5300-1.16
JNJ165.370.41000.25
FB336.775.51001.66
GE13.47-0.2200-1.61
JPM157.57-2.7200-1.70
Earnings HistoryEstimateReportedSurprise %
Q01 2021-0.09-0.19-111.11
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date2nd Aug 2021
Estimated EPS Next Report-0.10
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume159.40K
Shares Outstanding59.57M
Trades Count2.12K
Dollar Volume2.86M
Avg. Volume192.96K
Avg. Weekly Volume147.11K
Avg. Monthly Volume125.91K
Avg. Quarterly Volume138.35K

Clene Inc. (NASDAQ: CLNN) stock closed at 11.36 per share at the end of the most recent trading day (a 1.97% change compared to the prior day closing price) with a volume of 159.40K shares and market capitalization of 676.76M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 74 people. Clene Inc. CEO is Robert Etherington.

The one-year performance of Clene Inc. stock is 25.42%, while year-to-date (YTD) performance is 26.08%. CLNN stock has a five-year performance of %. Its 52-week range is between 6.23 and 16.5, which gives CLNN stock a 52-week price range ratio of 49.95%

Clene Inc. currently has a PE ratio of -7.30, a price-to-book (PB) ratio of 1 272.57, a price-to-sale (PS) ratio of 1 970.42, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -94.12%, a ROC of -% and a ROE of 152.71%. The company’s profit margin is -%, its EBITDA margin is -14 991.10%, and its revenue ttm is $349.00 Thousand , which makes it $0.01 revenue per share.

Of the last four earnings reports from Clene Inc., there were 0 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.10 for the next earnings report. Clene Inc.’s next earnings report date is 02nd Aug 2021.

The consensus rating of Wall Street analysts for Clene Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Clene Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Clene Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Clene Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 32.00, ATR14 : 0.86, CCI20 : 73.87, Chaikin Money Flow : 0.15, MACD : 0.46, Money Flow Index : 69.88, ROC : 8.92, RSI : 56.66, STOCH (14,3) : 70.61, STOCH RSI : 0.27, UO : 52.85, Williams %R : -29.39), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Clene Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Clene Inc.

Clene Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for neurodegenerative diseases..

CEO: Robert Etherington

Telephone: +1 801 676-9695

Address: 6550 South Millrock Drive, Salt Lake City 84121, UT, US

Number of employees: 74

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

News

Stocktwits